2024
Prescription of Nicotine Replacement Therapy for Hospitalized Tobacco Users
Nielsen E, Ware E, Heincelman M, Schreiner A, Lenert L, Toll B. Prescription of Nicotine Replacement Therapy for Hospitalized Tobacco Users. Southern Medical Journal 2024, 117: 517-520. PMID: 39094806, DOI: 10.14423/smj.0000000000001719.Peer-Reviewed Original ResearchConceptsNicotine replacement therapyPrescribed nicotine replacement therapyPrescription of nicotine replacement therapyNicotine replacement therapy prescriptionManagement of chronic conditionsHospitalized tobacco usersInitiate health behavior changeHealth behavior changeEmergency department visitsRate of prescriptionTobacco treatmentIncreased readmission ratesChronic conditionsHealth systemDepartment visitsRetrospective cohort studySmoking cessationTobacco usersInpatient admissionsReplacement therapyOutpatient settingCohort studyReadmission ratesSignificantly lower ratesCigarette smokingImplementation of an “opt-out” tobacco treatment program in six hospitals in South Carolina
Cummings K, Talbot V, Roberson A, Bliss A, Likins E, Brownstein N, Stansell S, Adams-Ludd D, Harris B, Louder D, McCutcheon E, Zebian R, Rojewski A, Toll B. Implementation of an “opt-out” tobacco treatment program in six hospitals in South Carolina. BMC Health Services Research 2024, 24: 741. PMID: 38886764, PMCID: PMC11184783, DOI: 10.1186/s12913-024-11205-7.Peer-Reviewed Original ResearchConceptsPost-discharge follow-up callsTobacco treatment programFollow-up callsEnhance careBasic careSmoking statusConsultation visitTobacco treatment specialistStop Smoking ServicesStop smoking medicationsAssess smoking statusResultsSmoking prevalenceSmoking ServicesMedical University of South CarolinaSmoking medicationsIntervention groupQuit ratesTreatment deliveryTreatment specialistsSurveyed patientsDaily smokersHigh caseloadsUniversity of South CarolinaHospital dischargeSouth Carolina
2012
Tobacco Quitlines Need to Assess and Intervene with Callers' Hazardous Drinking
Toll BA, Cummings KM, O'Malley SS, Carlin‐Menter S, McKee SA, Hyland A, Wu R, Hopkins J, Celestino P. Tobacco Quitlines Need to Assess and Intervene with Callers' Hazardous Drinking. Alcohol Clinical And Experimental Research 2012, 36: 1653-1658. PMID: 22703028, PMCID: PMC3436938, DOI: 10.1111/j.1530-0277.2012.01767.x.Peer-Reviewed Original ResearchConceptsSmoking cessation ratesCessation ratesBrief alcohol interventionHazardous drinkingHigh-risk drinkersQuitline callersTobacco quitlineCessation outcomesNIAAA guidelinesAlcohol interventionsLower smoking cessation ratesModerate alcohol consumptionShort-term followQuarter of smokersHazardous drinking patternsHigh rateSmoking cessationDaily smokersModerate drinkersSmoking relapseHazardous drinkersAlcohol consumptionSmokersDrinking patternsQuitline
2010
Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trial
Toll BA, White M, Wu R, Meandzija B, Jatlow P, Makuch R, O’Malley S. Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trial. Drug And Alcohol Dependence 2010, 111: 200-206. PMID: 20542391, PMCID: PMC3771701, DOI: 10.1016/j.drugalcdep.2010.04.015.Peer-Reviewed Original ResearchConceptsWeight gainSmoking cessationPoint prevalence smoking abstinence ratePre-specified primary outcomesLow-dose naltrexoneOpen-label therapySmoking abstinence ratesPoint prevalence abstinenceReduced weight gainNaltrexone augmentationPlacebo groupNicotine replacementPrimary outcomeQuit dateAbstinence ratesLabel therapyNicotine patchBehavioral counselingNaltrexoneAbstinent participantsSmokersWeight concernsWeeksCessationLower ratesRandomized Trial: Quitline Specialist Training in Gain-Framed vs Standard-Care Messages for Smoking Cessation
Toll BA, Martino S, Latimer A, Salovey P, O'Malley S, Carlin-Menter S, Hopkins J, Wu R, Celestino P, Cummings KM. Randomized Trial: Quitline Specialist Training in Gain-Framed vs Standard-Care Messages for Smoking Cessation. Journal Of The National Cancer Institute 2010, 102: 96-106. PMID: 20056957, PMCID: PMC2808347, DOI: 10.1093/jnci/djp468.Peer-Reviewed Original ResearchConceptsNew York State Smokers' QuitlineState Smokers' QuitlineSmoking cessationGain-framed messagesNicotine replacement therapySmoking cessation effortsCancer-related mortalitySmoking accountsCessation effortsReplacement therapyEligible callersQuitlineTreatment fidelityCessationCounselingSmokersHigh rateSpecialist trainingLarge proportionSpecialistsTherapyFollowMortalityAbstinenceEarly success
2007
Comparing Gain- and Loss-Framed Messages for Smoking Cessation With Sustained-Release Bupropion: A Randomized Controlled Trial
Toll BA, O'Malley SS, Katulak NA, Wu R, Dubin JA, Latimer A, Meandzija B, George TP, Jatlow P, Cooney JL, Salovey P. Comparing Gain- and Loss-Framed Messages for Smoking Cessation With Sustained-Release Bupropion: A Randomized Controlled Trial. Psychology Of Addictive Behaviors 2007, 21: 534-544. PMID: 18072836, PMCID: PMC2527727, DOI: 10.1037/0893-164x.21.4.534.Peer-Reviewed Original ResearchConceptsSustained-release bupropionSmoking cessationGain-framed messagesLoss-framed messagesTreat analysisControlled TrialsPoint prevalenceClinical trialsContinuous abstinencePrevention behaviorsTreatment completersCessationBupropionExperimental groupTrialsLoss-framed conditionHigher proportionGain-framed conditionParticipantsPrevalenceA preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain
Toll BA, Leary V, Wu R, Salovey P, Meandzija B, O'Malley SS. A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain. Addictive Behaviors 2007, 33: 173-179. PMID: 17587504, PMCID: PMC2488403, DOI: 10.1016/j.addbeh.2007.05.012.Peer-Reviewed Original ResearchConceptsPost-cessation weight gainWeight-concerned smokersPoint prevalence abstinenceWeight gainAbstinent participantsSustained-release bupropion hydrochlorideHigher smoking cessation ratesWeight suppressant effectsOpen-label studyPercentage of patientsSmoking cessation ratesLess weight gainDays of treatmentNaltrexone augmentationAdverse eventsCombination pharmacotherapyPrimary outcomeCessation ratesTreatment regimenCigarette smokersClinical trialsContinuous abstinenceLabel studyPsychosocial interventionsBupropion